PEDIATRICS INTERNATIONAL, cilt.45, sa.3, ss.314-318, 2003 (SCI-Expanded)
Objective: The present study was carried out to evaluate the safety and immunogenicity of the Haemophilus influenzae type b-CRM197 (Hib-CRM197) conjugate vaccine in relation to the change of adjuvant from aluminum hydroxide to aluminum phosphate (AlPO4).